Not all sufferers with CLL have to have therapy. Regardless of all latest advances, the iwCLL nevertheless recommends watchful observation for clients with asymptomatic illness.86 This suggestion relies on not less than two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR). ddbola selalu memberikan https://francisa974tcj1.is-blog.com/profile